HEAT BIOLOGICS Forum: Community User: Chillchef

https://www.heatbio.com/news-media/news-releases/detail/700/heat-biologics-to-provide-corporate-update

https://www.heatbio.com/news-media/news-releases/detail/699/heat-biologics-unveils-skunkworx-bio-new-drug-discovery

Heat Biologics Announces Addition of Former US Senator Mark Pryor to Biothreat Advisory Board DURHAM, N.C., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, announces the addition of Mark Pryor, former US Senator from the State of Arkansas, to the Company’s Biothreat Advisory Board. Former US Senator Mark Pryor currently serves with the premier law firm, Brownstein Hyatt Farber Schreck. He is a former two-term U.S. senator and Arkansas attorney general. During his 12 years representing Arkansas in the Senate, he worked across the aisle to pass more than 70 pieces of legislation on a range of critical issues, including homeland security and defense. Sen. Pryor served on several high-profile committees during his tenure, including Appropriations; Armed Services; Commerce, Science and Transportation; Homeland Security and Governmental Affairs. Jeff Wolf, Chief Executive Officer of Heat, commented, “As a leader on the Armed Services as well as the Homeland Security and Governmental Affairs committees, Senator Pryor brings unique expertise in policy and government affairs to our biothreat efforts. We look forward to leveraging Senator Pryor’s knowledge as we advance our new biothreat initiatives.” Senator Pryor joins David Lasseter, Former Deputy Assistant Secretary of Defense for Countering Weapons of Mass Destruction; Former US Representative Jack Kingston, who also serves as the Secretariat of the Alliance for Biosecurity; Andrew C. Weber, Former Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs; and Dr. Gregory Koblentz, Associate Professor at George Mason University and leading expert on chemical and biological weapons.

https://www.heatbio.com/news-media/news-releases/detail/697/heat-biologics-announces-new-additions-to-biothreat

Ist doch noch genug Geld da.

Bin mal gespannt was die neuen Herren kosten

https://newsfilter.io/a/c03d5bd36d36130f6cdff98cf6499223

https://www.heatbio.com/news-media/news-releases/detail/695/heat-biologics-provides-second-quarter-2021-business-update

Ösenzieher Diese news müsste sich ja etwas auf die HV auswirken bzw. auf die Zahlen.....wenn ich richtig liege

https://www.otcdynamics.com/htbx-heat-biologics-announces-groundbreaking-for-new-san-antonio-facility/

https://rapidvax.bio

Jahreshauptversammlung https://ir.heatbio.com/sec-filings-email/content/0001553350-21-000634/htbx_8k.htm

Das ist ein microcap Biotechnologie Unternehmen. Ich hoffe sehr, dass ich als Aktionär Ihnen scheiß egal bin. Sie sollen sich auf ihre Arbeit konzentrieren und nicht Aktionärspolitik betreiben.

Man wird das Gefühl nicht los das denen die Aktionäre scheiß egal sind. m.M.n

Solange wir keine brauchbare News sehen tut sich hier überhaupt nichts und es dürfte weiter abwärts gehen. Dazu kommt noch das das Umfeld im Moment auch nicht berauschend ist. Die letzten Mitteilungen waren nur aufgewärmter Mist.

https://worldsciencejobs.com/site-job/heatbio.com